Study summary · research use only
From pathogenesis of acne vulgaris to anti-acne agents
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review (species not specified) discusses acne vulgaris pathogenesis, describing four contributing factors: hyperseborrhea/dysseborrhea, altered keratinization of the pilosebaceous duct, Cutibacterium acnes, and inflammation, with androgens, insulin, and insulin-like growth factor-1 described as central hormones, alongside corticotropin-releasing hormone, alpha-melanocyte-stimulating hormone, and substance P. Signaling pathways discussed include Wnt/beta-catenin, PI3K/Akt, MAPK, AMPK, and NF-kB, with the IGF-1-induced PI3K/Akt/FoxO1/mTORC1 pathway described as most central. The review lists anti-acne agents in use (retinoids, benzoyl peroxide, antibiotics, hormonal agents) and newer agents under development, including PPARgamma modifiers, melanocortin receptor antagonists, epigallocatechin-3-gallate, metformin, olumacostat glasaretil, a stearoyl-CoA desaturase inhibitor, omiganan pentahydrochloride, KDPT, afamelanotide, apremilast, and biologics, describing a shared mechanism of attenuated Akt/mTORC1 and enhanced p53 signaling.
Abstract
Acne vulgaris is a cutaneous chronic inflammatory disorder with complex pathogenesis. Four factors play vital roles in acne pathophysiology: hyperseborrhea and dysseborrhea, altered keratinization of the pilosebaceous duct, Cutibacterium acnes (C. acnes) and inflammation. The main hormones responsible for the development of acne vulgaris include androgens, insulin and insulin-like growth factor-1. Other factors involved in this process are corticotropin-releasing hormone, α-melanocyte-stimulating hormone and substance P. Wnt/β-catenin signaling pathway, phosphoinositide 3-kinase (PI3K)/Akt pathway, mitogen-activated protein kinase pathway, adenosine 5'-monophosphate-activated protein kinase pathway and nuclear factor kappa B pathway participate in the modulation of sebocyte, keratinocyte and inflammatory cell (e.g. lymphocytes, monocytes, macrophages, neutrophils) activity. Among all the triggers and pathways mentioned above, IGF-1-induced PI3K/Akt/Forkhead box protein O1/mammalian target of rapamycin (mTOR) C1 pathway is the most important signaling responsible for acne pathogenesis. Commonly used anti-acne agents include retinoids, benzoyl peroxide, antibiotics and hormonal agents (e.g. spironolactone, combination oral contraceptive and flutamide). New approaches including peroxisome proliferator-activated receptor γ modifier, melanocortin receptor antagonists, epigallocatechin-3-gallate, metformin, olumacostat glasaretil, stearoyl-CoA desaturase inhibitor omiganan pentahydrochloride, KDPT, afamelanotide, apremilast and biologics have been developed as promising treatments for acne vulgaris. Although these anti-acne agents have various pharmacological effects against the diverse pathogenesis of acne, all of them have a synergistic mode of action, the attenuation of Akt/mTORC1 signaling and enhancement of p53 signal transduction. In addition to drug therapy, diet with no hyperglycemic carbohydrates, no milk and dairy products is also beneficial for treatment of acne.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.